| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | CA2019580C Novel methods of treatment using ranolazine and related piperazine derivatives |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | US20070067861 Cloning pigs using donor nuclei from differentiated cells |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066618 Use of EP4 Receptor Ligands in the Treatment of IL-6 Involved Diseases |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/21/2007 | EP1397492B1 Modified and stabilized gdf propeptides and uses thereof |
| 03/21/2007 | EP1216024B1 Formulation for menopausal women |
| 03/21/2007 | CN1934256A Decoy nucleic acid to synoviolin gene promoter |
| 03/21/2007 | CN1932016A Polynucleotide affecting SRE activity and its coding polypeptides and use |
| 03/21/2007 | CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/20/2007 | US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192924 Corticotropin releasing factor 2 receptor agonists |
| 03/20/2007 | US7192923 For therapy and prophylaxis of muscular dystrophy |
| 03/20/2007 | US7192717 GASP1: a follistatin domain containing protein |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/15/2007 | WO2007028210A1 Milk derived composition and use to enhance muscle mass or muscle strength |
| 03/15/2007 | US20070060572 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 03/15/2007 | US20070060546 Novel use of mifepristone and derivatives therefor as hedgehog protein signaling pathway modulators and applications of same |
| 03/15/2007 | US20070059831 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 03/15/2007 | US20070059369 Subcutaneous delivery system, process for the preparation of the same and use of the same for the treatment of cholinergic deficient disorders |
| 03/15/2007 | US20070059305 Neutralizing human anti-IGFR antibody |
| 03/15/2007 | US20070059241 neutralizing monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1); anticancer agent |
| 03/15/2007 | CA2640796A1 Milk derived composition and use to enhance muscle mass or muscle strength |
| 03/14/2007 | EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same |
| 03/14/2007 | CN1930186A Media for clostridium bacterium and processes for obtaining a clostridial toxin |
| 03/14/2007 | CN1927269A Application of Cinnamomum cassia extract for preventing and treating muscular dystrophy |
| 03/14/2007 | CN1304383C Benzothiazole derivatives |
| 03/14/2007 | CN1304375C Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions |
| 03/14/2007 | CN1304374C Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition |
| 03/14/2007 | CN1304009C Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 03/13/2007 | US7189878 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 03/13/2007 | US7189870 Cardiovascular disorders; antiinflammatory agents |
| 03/13/2007 | US7189854 Reacting 4-(2-hydroxyethyl)piperazine and 2-((2-methyl,6-chloro-pyrimidin-4-yl)-amino),5-(2-chloro,6-methyl-phenyl)thiazole to obtain 2-((2-hydroxyethyl)piperazin-4-yl)-(2-methylpyrimidin-6,4-ylene)amino-),5-(2-chloro,6-methyl-phenyl)thiazole; antiarthritic,-tumor, -carcinogentic agents; immunology |
| 03/13/2007 | US7189837 Cell surface molecule-induced macrophage activation |
| 03/13/2007 | US7189820 Antibody for use in the treatment, prevention and diagnosis of cancer, autoimmune, arthritic and graft vs. host diseases |
| 03/13/2007 | US7189389 Pharmaceutical composition of human interferon-α2 and interferon α8 subtypes |
| 03/13/2007 | CA2420895C Method for treating erectile dysfunction and increasing libido in men |
| 03/13/2007 | CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 03/13/2007 | CA2274314C Insulin-like growth factor i (igf-i) expression system and methods of use |
| 03/08/2007 | WO2007026771A1 Injection for intravenous drip |
| 03/08/2007 | US20070054913 4-(2-Butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 03/08/2007 | US20070054904 Phenol derivatives and their use as rotamase inhibitors |
| 03/07/2007 | EP1368304B1 Prodrugs of excitatory amino acids |
| 03/07/2007 | EP1333840B1 M. tuberculosis chaperonin 60.1 and uses thereof |
| 03/07/2007 | EP1032387B1 Novel metal complexes |
| 03/07/2007 | EP1003784B1 Novel peptides and polypeptides useful for regenerating the nervous system |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | CN1926115A Novel therapeutic agent for amyotrophic lateral sclerosis(ALS) or disease attributable to ALS |
| 03/07/2007 | CN1923812A New compounds |
| 03/07/2007 | CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 03/07/2007 | CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 03/07/2007 | CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 03/07/2007 | CN1302811C Externally-applicated chewing gum including chip-like center |
| 03/06/2007 | US7186840 Quinoline derivatives as anti-inflammatory agents |
| 03/06/2007 | US7186838 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 03/06/2007 | US7186826 Phosphorus-containing compounds and uses thereof |
| 03/06/2007 | US7186737 Inhibitors of p38 |
| 03/06/2007 | US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders |
| 03/06/2007 | US7186720 Moderator of tumor necrosis factor; antiinflammatory agents; autoimmune diseases |
| 03/01/2007 | WO2007024673A1 Use of ranodine receptor antagonists to trat amotrophic lateral scerosis |
| 03/01/2007 | WO2007023896A1 Muscle pain suppressant and functional food for muscle pain suppression |
| 03/01/2007 | WO2007023880A1 Chemokine production inhibitor |
| 03/01/2007 | WO2007023875A1 Technique for culture of mesenchymal stem cell utilizing laminin-5 |
| 03/01/2007 | WO2007022951A1 Use of n-(dibenz (b,f)oxepin-10-ylmethyl)-n-methyl-n-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy |
| 03/01/2007 | WO2006119965A3 Growth factor mutants with altered biological attributes |
| 03/01/2007 | WO2006078056A8 Drugs for activating muscle satellite cell |
| 03/01/2007 | US20070049735 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070049594 Novel compounds and compositions as cathepsin inhibitors |
| 03/01/2007 | US20070048846 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 03/01/2007 | US20070048804 Methods of detecting cytokine receptor zcytor19 ligand |
| 03/01/2007 | US20070048799 hematopoietic cytokine receptor polypeptide encoded by nucleotides equences for use in the treatment of cancer; restoring normal blood cell levels in patients suffering from anemia, thrombocytopenia, and neutropenia or receiving chemotherapy for cancer; biodrugs |
| 03/01/2007 | US20070048319 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048298 administering nucleoproteins such as retinoblastoma associated protein 48 suppressor or inhibitors, used for prophylaxis of Sjogren's syndrome, as diagnostic agents or screening antiapoptosic agents |
| 03/01/2007 | US20070048221 Antibodies that bind both bcma and taci |
| 03/01/2007 | US20070048220 Antibodies that bind both bcma and taci |
| 03/01/2007 | CA2619491A1 Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders |
| 02/28/2007 | EP1757584A1 Heterocyclic substituted amides, their production and their use |
| 02/28/2007 | EP1757325A1 Use of botulinum toxin for treating myofascial pain |
| 02/28/2007 | EP1757284A1 Use of N-(dibenz(b,f)oxepin-10ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy |
| 02/28/2007 | EP1755614A1 Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome |
| 02/28/2007 | EP1755592A1 Use of c-kit inhibitors for treating inflammatory muscle disorders including myositis and muscular dystrophy |
| 02/28/2007 | EP1755559A1 Bioavailable solid dosage forms of metaxalone |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1368094B1 4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl) pyrazolo- 1,5-a|-1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 02/28/2007 | EP1301201B1 Treatment of glycogen storage disease type ii |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/27/2007 | US7183436 Substituted 4-aminocyclohexanols |
| 02/27/2007 | US7183390 Humanized antibodies to gamma-interferon |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183112 Administering locally to the area of inflammation to an animal an anti-inflammatory effective amount of an anti-malaria compound which is aminoquinoline or derivative |